Advisory Alpha’s Gilead Sciences GILD Stock Holding History

Advisory Alpha’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$355K	Buy	2,550 +106	+4%	+$14.8K	0.01%	412
2025 Q4	$300K	Sell	2,444 -142	-5%	-$17.3K	0.01%	421
2025 Q3	$286K	Sell	2,586 -799	-24%	-$90.8K	0.01%	427
2025 Q2	$375K	Sell	3,385 -151	-4%	-$16.1K	0.01%	321
2025 Q1	$396K	Buy	3,536 +721	+26%	+$74.4K	0.01%	288
2024 Q4	$260K	Buy	+2,815	New	+$253K	0.01%	358
2020 Q4	–	Sell	-441	Closed	-$28K	–	303
2020 Q3	$28K	Buy	+441	New	+$30.6K	0.01%	278
2020 Q2	–	Sell	-515	Closed	-$40.1K	–	286
2020 Q1	$40.1K	Buy	515 +172	+50%	+$11.9K	0.01%	232
2019 Q4	$22.1K	Buy	343 +96	+39%	+$6.25K	0.01%	394
2019 Q3	$15.3K	Buy	+247	New	+$16.1K	﹤0.01%	404
2019 Q2	–	Sell	-883	Closed	-$58.4K	–	316
2019 Q1	$58.4K	Buy	+883	New	+$58.7K	0.02%	214

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Advisory Alpha's GILD Position: Q1 2026 in Review

Advisory Alpha increased its Gilead Sciences (GILD) stake by 4.3% in Q1 2026, buying an estimated $14.8K and bringing the position to 2,550 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #412.

Advisory Alpha first reported a position in GILD in Q1 2019 and has held it in 11 quarters since. The position peaked at $396K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Advisory Alpha held 2,550 shares of Gilead Sciences worth $355K as of Q1 2026.
Advisory Alpha bought 106 Gilead Sciences shares in Q1 2026, an estimated $14.8K.
Gilead Sciences made up 0.01% of Advisory Alpha's portfolio in Q1 2026, its #412 holding.
Advisory Alpha first reported a position in Gilead Sciences in Q1 2019 and has held it in 11 quarters since.
Advisory Alpha's Gilead Sciences position peaked at $396K in Q1 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.